Fitzgerald Meghan — SEC Form 4 filings
SEC reporting owner CIK 1349297. 16 Form 4 filings on record with FilingPulse; latest filed 2026-09-18.
Transaction summary — filings shown
Covers all 16 filings on record, filed 2024-01-23 to 2026-09-18. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 6 legs across 5 filings — 125,112 shares, $6,198,452 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 27.
- Largest priced transaction: sale of 20,000 shares @ $146.34 ($2,926,800) in TENET HEALTHCARE CORP, filed 2024-08-08.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Roivant Sciences Ltd. (ROIV) | Director | 11 | — | 5 legs · 105,112 sh · $3,271,652 | 18 |
| TENET HEALTHCARE CORP (THC) | Director | 5 | — | 1 leg · 20,000 sh · $2,926,800 | 9 |
Form 4 filings — Fitzgerald Meghan
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-18 | 4 | Roivant Sciences Ltd. (ROIV) | Grant/award (A): 5,054 @ $0 · Grant/award (A): 10,531 (derivative) @ $0 | EDGAR |
| 2026-09-17 | 4 | Roivant Sciences Ltd. (ROIV) | Sale (S): 4,712 @ $39.68 · Sale (S): 400 @ $40.45 | EDGAR |
| 2026-09-14 | 4 | Roivant Sciences Ltd. (ROIV) | Tax withholding (F): 1,743 @ $40.94 | EDGAR |
| 2026-09-10 | 4 | Roivant Sciences Ltd. (ROIV) | Option exercise (M): 20,000 @ $8.80 · Sale (S): 20,000 @ $39.90 · Option exercise (M): 20,000 (derivative) @ $0 | EDGAR |
| 2026-07-02 | 4 | Roivant Sciences Ltd. (ROIV) | Option exercise (M): 10,000 @ $8.80 · Sale (S): 10,000 @ $34.90 · Option exercise (M): 10,000 (derivative) @ $0 | EDGAR |
| 2026-05-28 | 4 | TENET HEALTHCARE CORP (THC) | Grant/award (A): 1,188 (derivative) @ $0 | EDGAR |
| 2026-05-26 | 4 | TENET HEALTHCARE CORP (THC) | Option exercise (M): 1,333 · Disposition to issuer (D): 493 @ $173.78 · Option exercise (M): 1,333 (derivative) | EDGAR |
| 2026-03-30 | 4 | Roivant Sciences Ltd. (ROIV) | Option exercise (M): 70,000 @ $8.80 · Sale (S): 70,000 @ $27.45 · Option exercise (M): 70,000 (derivative) @ $0 | EDGAR |
| 2025-09-12 | 4 | Roivant Sciences Ltd. (ROIV) | Grant/award (A): 14,524 @ $0 · Other (J): 937 @ $13.77 · Grant/award (A): 33,726 (derivative) @ $0 | EDGAR |
| 2025-05-27 | 4 | TENET HEALTHCARE CORP (THC) | Option exercise (M): 1,551 · Disposition to issuer (D): 573 @ $161.33 · Grant/award (A): 1,333 (derivative) @ $0 · Option exercise (M): 1,551 (derivative) | EDGAR |
| 2024-09-16 | 4 | Roivant Sciences Ltd. (ROIV) | Other (J): 894 @ $12.12 | EDGAR |
| 2024-09-12 | 4 | Roivant Sciences Ltd. (ROIV) | Grant/award (A): 16,406 @ $0 · Grant/award (A): 27,894 (derivative) @ $0 | EDGAR |
| 2024-08-08 | 4 | TENET HEALTHCARE CORP (THC) | Sale (S): 20,000 @ $146.34 | EDGAR |
| 2024-05-28 | 4 | TENET HEALTHCARE CORP (THC) | Grant/award (A): 1,551 (derivative) @ $0 | EDGAR |
| 2024-04-26 | 4 | Roivant Sciences Ltd. (ROIV) | Grant/award (A): 1,261 @ $0 · Tax withholding (F): 83 @ $10.90 | EDGAR |
| 2024-01-23 | 4 | Roivant Sciences Ltd. (ROIV) | Grant/award (A): 1,328 @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1349297 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →